Literature DB >> 25910971

EX-PRESS glaucoma filtration device: Review of clinical experience and comparison with trabeculectomy.

Tarek Shaarawy1, Ivan Goldberg2, Robert Fechtner3.   

Abstract

Glaucoma filtration surgery is performed to reduce intraocular pressure (IOP) in patients for whom maximal tolerable pharmacologic IOP-lowering therapy and/or laser surgery fail to lower IOP sufficiently and/or fail to prevent optic nerve damage or visual field deterioration. For decades, the most widely utilized procedure for glaucoma filtration surgery has been trabeculectomy. Although this approach reliably provides long-term IOP reduction in many patients, the postoperative complication rate is high. This has driven the development of alternative approaches to reduce IOP surgically. The EX-PRESS glaucoma filtration device was developed to mimic IOP control by trabeculectomy and to have a better safety profile. This non-valved, medical-grade stainless steel device diverts aqueous humor from the anterior chamber to an intrascleral space. Despite the widespread use of the EX-PRESS device, only a few studies compare its efficacy and safety with that of trabeculectomy. We analyze available data regarding the safety and efficacy of the EX-PRESS device, particularly in comparison with trabeculectomy.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  glaucoma; glaucoma filtration device; intraocular pressure; postoperative complications; trabeculectomy

Mesh:

Year:  2015        PMID: 25910971     DOI: 10.1016/j.survophthal.2015.01.001

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  14 in total

1.  Twelve-month efficacy and safety of glaucoma filtration device for surgery in patients with normal-tension glaucoma.

Authors:  Makoto Aihara; Yasuaki Kuwayama; Kazunori Miyata; Shinichiro Ohtani; Ryuichi Ideta; Yoshihiro Hashimoto; Noriyuki Sasaki; Shiroaki Shirato
Journal:  Jpn J Ophthalmol       Date:  2019-07-31       Impact factor: 2.447

2.  Visual acuity and corneal higher-order aberrations after EX-PRESS or trabeculectomy, and the determination of associated factors that influence visual function.

Authors:  Nobuko Kobayashi; Kazuyuki Hirooka; Eri Nitta; Kaori Ukegawa; Akitaka Tsujikawa
Journal:  Int Ophthalmol       Date:  2017-08-10       Impact factor: 2.031

3.  Clinical outcomes after Ex-PRESS glaucoma shunt versus non-penetrating deep sclerectomy: two-year follow-up.

Authors:  Beatriz Puerto; Cristina López-Caballero; Carmen Sánchez-Sánchez; Noelia Oblanca; Vanesa Blázquez; Inés Contreras
Journal:  Int Ophthalmol       Date:  2017-11-24       Impact factor: 2.031

4.  Surgical outcomes of patients with iridocorneal endothelial syndrome: a case series.

Authors:  Serhat Imamoglu; Mehmet S Sevim; Hatice Elvin Yıldız; Ece Turan Vural; Handan Bardak; Yavuz Bardak
Journal:  Int Ophthalmol       Date:  2016-08-06       Impact factor: 2.031

5.  Short-term change in higher-order aberrations after mitomycin-C-augmented trabeculectomy.

Authors:  Seong Ho Jo; Je Hyun Seo
Journal:  Int Ophthalmol       Date:  2017-12-22       Impact factor: 2.031

6.  Long-term efficacy and safety of ExPress implantation for treatment of open angle glaucoma.

Authors:  Geun Young Lee; Chong Eun Lee; Kyoo Won Lee; Sam Seo
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

7.  Efficacy of selective laser trabeculoplasty following incisional glaucoma surgery.

Authors:  Robert Allan Sharpe; Leah L Kammerdiener; David B Williams; Sudeep K Das; Matthew J Nutaitis
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

8.  Effect of glaucoma implant surgery on intraocular pressure reduction, flare count, anterior chamber depth, and corneal endothelium in primary open-angle glaucoma.

Authors:  Kyoko Ishida; Naoya Moroto; Kazuhiro Murata; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2017-04-03       Impact factor: 2.447

9.  Outcomes of Ex-PRESS and Trabeculectomy in a Glaucoma Population of African Origin: One Year Results.

Authors:  Youssef Dib Bustros; Robert Fechtner; Albert S Khouri
Journal:  J Curr Glaucoma Pract       Date:  2017-08-05

10.  Commentary: Decoding the Ex-PRESS® implant.

Authors:  Manish Panday
Journal:  Indian J Ophthalmol       Date:  2019-09       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.